Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ca254cb6a2c92ef3429fd434c71a5d7d http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a153f0a1b53fa754774ff1f85464faa6 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-006 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-404 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-404 |
filingDate |
2009-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_748b8aa37c9c6851e494f2e62235d3e9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_03807056c34722ced3586d75bd43b28d |
publicationDate |
2010-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-2252263-A1 |
titleOfInvention |
Galenic form for the oral transmucosal delivery of triptans |
abstract |
The invention relates to a galenic form for the oral transmucosal delivery of at least one active ingredient of the family of triptans, comprising at least: said active ingredient in base form and in salt form, and an aqueous-alcoholic solution with a titer of at least 15 degrees alcohol, said active ingredient being present in a stable and complete dissolution state in the aqueous-alcoholic solution, for rapid absorption of said active ingredient through the mucosa of the oral cavity and/or of the oropharynx. The invention also relates to a method for obtaining this galenic formulation and to the use thereof. |
priorityDate |
2008-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |